Article Details

Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 ...

Retrieved on: 2021-06-10 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 .... View article details on HISWAI: https://www.hospimedica.com/covid-19/articles/294788547/engineered-igm-antibody-administered-intranasally-may-be-more-potent-at-inhibiting-sars-cov-2-and-its-variants-than-current-antibody-therapies.html

Excerpt

An IgM version of an anti-SARS-CoV-2 IgG monoclonal antibody is being developed as an intranasally administered agent for the treatment and ...

Article found on: www.hospimedica.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up